课题基金 / 基金详情

Molecular-targeted therapy of venous thromboembolism

Molecular-targeted therapy of venous thromboembolism
静脉血栓栓塞的分子靶向治疗
批准号:
22791206
负责人:
FURUKOUJI Eiji
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

FURUKOUJI Eiji的其他基金

相似基金

相关文献

中文摘要
翻译
血小板活化受体CLEC-2与podoplanin结合,从而导致血小板活化和血栓形成。本研究探讨腺病毒介导的基因转移到静脉壁后,局部基因转移是否抑制血小板聚集和血栓形成竞争。因此,尽管需要进一步的研究,但在大鼠静脉血栓形成模型中提示了靶蛋白持续表达和抗血栓形成作用的可能性。
英文摘要
Platelet activation receptor CLEC-2 binds to podoplanin, thereby leading to platelet activation and thrombus formation. The present study examines whether local gene transfer suppress platelet aggregation and thrombus formation after adenovirus-mediated gene transfer to venous wall competitively. As a result, although further studies are needed, the possibility of persistent expression of target protein and antithrombotic effect were suggested in a rat model of venous thrombosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The local gene transfer for prevention of deep vein thrombosis
  • 批准号:
    20790901
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.33万
  • 财政年份:
    2008
  • 负责人:
    FURUKOUJI Eiji
  • 依托单位:
海外基金